http://archive.mail-list.com/hbv_research/message/20100728.115823.38b1d145.en.html
although this therapy is far from the market it shows that decrease of hbsag inhibits HBV replication and this is nothing new, and we also know it stops immune system depression against hbv too, the great news is that hbsag decline by 70% can also inhibit HCC growth